| 1.2 |
3.5 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.6 |
2.3 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.3 |
1.5 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.3 |
0.8 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.3 |
0.8 |
GO:1904395 |
retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.3 |
2.1 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) myoblast fate commitment(GO:0048625) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.2 |
0.7 |
GO:0100012 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
| 0.2 |
1.0 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.2 |
0.7 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.2 |
0.9 |
GO:1903615 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.2 |
3.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
1.0 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 |
0.5 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.1 |
1.0 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.9 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
2.0 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.9 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 |
0.4 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.1 |
1.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.1 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.1 |
0.7 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.5 |
GO:0035948 |
N-terminal peptidyl-lysine acetylation(GO:0018076) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 |
0.6 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
0.1 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.1 |
0.1 |
GO:0009996 |
negative regulation of cell fate specification(GO:0009996) |
| 0.1 |
0.3 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.1 |
0.3 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 |
0.7 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.1 |
0.4 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.1 |
1.7 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.1 |
0.5 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.1 |
0.5 |
GO:1903906 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.1 |
0.3 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.1 |
1.1 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
2.4 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
2.1 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
1.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.6 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.4 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.7 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 |
0.3 |
GO:2000174 |
regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.1 |
0.3 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.1 |
0.4 |
GO:0007509 |
mesoderm migration involved in gastrulation(GO:0007509) |
| 0.1 |
0.8 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 |
0.5 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.1 |
0.5 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 |
0.2 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.1 |
0.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.2 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.1 |
0.7 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
0.6 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 |
0.2 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.1 |
0.5 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.1 |
0.3 |
GO:0021823 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.1 |
0.2 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.5 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 |
0.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.5 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 0.1 |
0.3 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.7 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 |
0.2 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.1 |
0.2 |
GO:1902823 |
negative regulation of late endosome to lysosome transport(GO:1902823) regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.1 |
0.5 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.2 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
0.7 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.0 |
0.6 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.0 |
0.1 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.0 |
0.9 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.9 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.0 |
2.3 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
0.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.7 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.2 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 |
0.5 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.2 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.0 |
0.2 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.3 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.0 |
0.2 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.0 |
0.3 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.1 |
GO:0061075 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.0 |
1.1 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.3 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
0.2 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.0 |
0.2 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.0 |
0.4 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.3 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.9 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.3 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.0 |
0.3 |
GO:1901297 |
regulation of Wnt signaling pathway involved in heart development(GO:0003307) positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.0 |
0.3 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.0 |
1.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 |
0.2 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.5 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.1 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.0 |
0.1 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.0 |
0.1 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.0 |
0.2 |
GO:0019856 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.0 |
0.6 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.7 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.4 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.1 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.0 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.6 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.2 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 |
0.2 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.1 |
GO:0090269 |
fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.0 |
0.2 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
1.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.4 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.0 |
0.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.5 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.6 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.0 |
0.3 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.3 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 |
0.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.1 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.0 |
0.3 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.4 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.7 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.1 |
GO:0031952 |
regulation of protein autophosphorylation(GO:0031952) |
| 0.0 |
0.1 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 |
0.3 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 |
0.1 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.0 |
1.2 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.4 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.2 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.3 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.4 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.0 |
0.2 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 |
0.8 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.1 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 |
0.3 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
0.1 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.0 |
0.2 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.2 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
0.2 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.0 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.0 |
0.5 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.2 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.0 |
0.6 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.1 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 |
0.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.0 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.0 |
0.2 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.0 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.0 |
0.2 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.3 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 |
0.1 |
GO:0034670 |
chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.0 |
0.3 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.6 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.0 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.0 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.2 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.6 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.4 |
GO:0006111 |
regulation of gluconeogenesis(GO:0006111) |
| 0.0 |
0.0 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 |
0.0 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.0 |
0.0 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.0 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
